The World Health Organization states pharmaceuticals represented a US $300 billion-a-year market globally as of 2015. The global pharmaceutical market is expected to surpass the US $400 billion by 2018, with the ten largest pharmaceutical companies altogether commanding about a third of the market. Companies in the pharmaceutical industry are symbolized by their sizeable expenditure on Research and Development and marketing initiatives in a bid to collect more revenue. The development of biopharmaceuticals serves a breakthrough for the industry and personalized therapies carry extremely large promise in the near future. Although mature markets continue to account for over half of all global revenue of the pharmaceutical industry, both large and alcove pharmaceutical companies are now waking up to the profitable potential that lies in growth markets.
The healthcare industry deals with the storage, exchange and management of healthcare records between laboratories, insurance agencies, hospitals, patients, and government bodies. The healthcare industry has seen aggressive growth over the last few years. New advances in the information technology domain, connected with the changing demands of patients and healthcare institutions, are combining to shape the future of the global healthcare information technology industry. Many countries are already taking the initiative in implementing extensive Electronic Health Records (EHRs) and as this trend spreads to more countries, several new areas will continue to emerge in the healthcare industry.
Pegvisomant(trade nameᅠSomavert) is aᅠgrowth hormone receptorᅠantagonistᅠused in the treatment ofᅠacromegaly. This report aims to provide a comprehensive presentation of the global market for Somavert, with both quantitative and qualitative analysis, to help readers develop business/growth [...]
READ MOREPegvisomant(trade nameᅠSomavert) is aᅠgrowth hormone receptorᅠantagonistᅠused in the treatment ofᅠacromegaly. This report aims to provide a comprehensive presentation of the global market for Pegvisomant Drugs, with both quantitative and qualitative analysis, to help readers develop busine [...]
READ MORELanreotideᅠ(INN) is a medication used in the management ofᅠacromegalyᅠand symptoms caused byᅠneuroendocrine tumors, most notablyᅠcarcinoid syndrome This report aims to provide a comprehensive presentation of the global market for Lanreotide Drugs, with both quantitative and qualitative ana [...]
READ MORESomatuline is a medication used in the management ofᅠacromegalyᅠand symptoms caused byᅠneuroendocrine tumors, most notablyᅠcarcinoid syndrome This report aims to provide a comprehensive presentation of the global market for Somatuline Drugs, with both quantitative and qualitative analysis, t [...]
READ MOREPegvisomant(trade nameᅠSomavert) is aᅠgrowth hormone receptorᅠantagonistᅠused in the treatment ofᅠacromegaly. This report aims to provide a comprehensive presentation of the global market for Pegvisomant, with both quantitative and qualitative analysis, to help readers develop business/gro [...]
READ MORESignifor is anᅠorphan drugᅠapproved in the United Statesᅠand Europe for the treatment ofᅠCushing's diseaseᅠin patients who fail or are ineligible for surgical therapy. This report aims to provide a comprehensive presentation of the global market for Signifor Drugs, with both quantitative a [...]
READ MOREPasireotide is anᅠorphan drugᅠapproved in the United Statesᅠand Europe for the treatment ofᅠCushing's diseaseᅠin patients who fail or are ineligible for surgical therapy. This report aims to provide a comprehensive presentation of the global market for Pasireotide Drugs, with both quantita [...]
READ MOREOctreotideᅠ(trade nameᅠSandostatin, among others) is anᅠoctapeptideᅠthat mimics naturalᅠsomatostatinᅠpharmacologically, though it is a more potent inhibitor ofᅠgrowth hormone,ᅠglucagon, andᅠinsulinᅠthan the natural hormone. This report aims to provide a comprehensive presentation [...]
READ MORELanreotideᅠ(INN) is a medication used in the management ofᅠacromegalyᅠand symptoms caused byᅠneuroendocrine tumors, most notablyᅠcarcinoid syndrome This report aims to provide a comprehensive presentation of the global market for Lanreotide, with both quantitative and qualitative analysis, [...]
READ MORESignifor is anᅠorphan drugᅠapproved in the United Statesᅠand Europe for the treatment ofᅠCushing's diseaseᅠin patients who fail or are ineligible for surgical therapy. This report aims to provide a comprehensive presentation of the global market for Signifor, with both quantitative and qua [...]
READ MORE